Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “RSV Immunization”

73 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 73 results

Testing effectiveness (Phase 2)Study completedNCT03334695
What this trial is testing

An Exploratory Study to Evaluate the Prophylactic Efficacy of a Single Immunization of Ad26.RSV.preF Against Respiratory Syncytial Virus Infection in a Virus Challenge Model in Healthy 18 to 50 Year-old Adults

Who this might be right for
Healthy
Janssen Vaccines & Prevention B.V. 64
Not applicableLooking for participantsNCT07171164
What this trial is testing

Evaluate Community-Based Measures to Increase RSV Vaccine Use Among Latino Adults

Who this might be right for
Older Adults Without Any Specific Clinical ConditionSocial NetworksRSV Immunization+1 more
University of California, San Francisco 750
Early research (Phase 1)Active Not RecruitingNCT06564194
What this trial is testing

Evaluate JCXH-108, an mRNA-based Vaccine Against RSV

Who this might be right for
Respiratory Syncytial Virus (RSV)Infectious Disease
Immorna Biotherapeutics, Inc. 75
Large-scale testing (Phase 3)Not Yet RecruitingNCT07041190
What this trial is testing

Pregnancy and Infant PrEparedness pLatform IN Europe, RSV-International Adaptive Platform Trial to Evaluate Two Approved Prevention Options to Prevent Respiratory Syncytial Virus in Infants: Maternal Vaccine to Women in Pregnancy and Monoclonal Antibody to the Infants, Given Alone or in Combination.

Who this might be right for
RSV Immunization
PENTA Foundation 1,500
Testing effectiveness (Phase 2)Active Not RecruitingNCT06984094
What this trial is testing

Safety and Immunogenicity Study of SCB-1022 and SCB-1033 in Healthy Older Adults

Who this might be right for
RSV InfectionHuman Metapneumovirus InfectionParainfluenza Infection
Clover Biopharmaceuticals AUS Pty 612
Early research (Phase 1)Study completedNCT01905215
What this trial is testing

Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccines

Who this might be right for
Infections, Respiratory Syncytial Virus
GlaxoSmithKline 128
Not applicableUnknownNCT06259487
What this trial is testing

Coordinated Vaccination Against RSV and Influenza in Patients With Chronic Heart Failure and Its Impact on Prognosis.

Who this might be right for
Heart FailureRSV InfectionInfluenza+1 more
Wroclaw Medical University 250
Not applicableStudy completedNCT02273882
What this trial is testing

An Observational Study of Respiratory Syncytial Virus (RSV) Hospitalizations in Preterm Infants

Who this might be right for
Respiratory Syncytial Virus Hospitalizations
AstraZeneca 497
Testing effectiveness (Phase 2)Looking for participantsNCT07734649
What this trial is testing

Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older

Who this might be right for
Respiratory Syncytial Virus ImmunizationHuman Metapneumovirus ImmunizationHealthy Volunteers
Sanofi 2,400
Not applicableActive Not RecruitingNCT06647654
What this trial is testing

Impact and Effectiveness of ABRYSVO® Vaccination During Pregnancy

Who this might be right for
Respiratory Syncytial VirusRespiratory Tract Diseases
Pfizer 1
Testing effectiveness (Phase 2)Study completedNCT04785612
What this trial is testing

Study of RSVpreF Vaccination and RSV Challenge in Healthy Adults

Who this might be right for
Respiratory Syncytial Virus Infections
Hvivo 70
Early research (Phase 1)Study completedNCT07071558
What this trial is testing

Study to Evaluate the Safety and Immunogenicity of Investigational Vaccines Using the RSV (Respiratory Syncytial Virus) Monovalent Antigen in Healthy Participants 18 to 49 Years of Age

Who this might be right for
Respiratory Syncytial Virus Immunization
Sanofi 240
Post-approval studies (Phase 4)Looking for participantsNCT07097012
What this trial is testing

Concurrent Versus Sequential Administration of Tdap and RSV Vaccines in Pregnancy

Who this might be right for
RSVTdap - Tetanus, Diphtheria and Acellular Pertussis VaccinationPregnancy+1 more
Canadian Immunization Research Network 60
Post-approval studies (Phase 4)Looking for participantsNCT07158814
What this trial is testing

Safety of RSV Preventive Monoclonal Antibody

Who this might be right for
FeverAdverse Event Following Immunisation
Duke University 524
Large-scale testing (Phase 3)Looking for participantsNCT07232706
What this trial is testing

Prevention of RSV Infection in Infants by Administering Nirsevimab to Infants, With or Without Maternal RSV Vaccination

Who this might be right for
RSV Immunization
Centre Hospitalier Annecy Genevois 1,000
Large-scale testing (Phase 3)Looking for participantsNCT07203365
What this trial is testing

RSV Immunogenicity Study in the Elderly (RISE)

Who this might be right for
RSV Immunisation
Karin Karin Loré 65
Not applicableNot Yet RecruitingNCT07235397
What this trial is testing

Evaluating the Benefits of RSV Maternal Vaccination Using a Scottish National Dataset

Who this might be right for
Respiratory Syncytial Virus Infections
Pfizer 1
Not applicableStudy completedNCT06824207
What this trial is testing

Repeated Cross Sectional Surveillance Study To Determine the Respiratory Syncytial Virus (RSV) Immunization Rates in German Infants

Who this might be right for
Respiratory Syncytial Virus Immunization
Sanofi Pasteur, a Sanofi Company 2,400
Large-scale testing (Phase 3)Active Not RecruitingNCT06534892
What this trial is testing

An Extension and Crossover Vaccination Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus Given to Adults 60 Years of Age and Above Who Participated in RSV OA=ADJ-006 Study

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 10,212
Not applicableLooking for participantsNCT07615192
What this trial is testing

RSV Immunisation Status in Queensland (Australia)

Who this might be right for
RSV Immunization
Sanofi 1,200
Next Page